Skip to main content

Want a detailed portfolio tracker?

ProQR Therapeutics N.V (PRQR) P/E (2014 - 2026)

ProQR Therapeutics N.V (PRQR) P/E from Sep 18, 2014 to Jun 3, 2026. The TTM ProQR Therapeutics N.V (PRQR) P/E is -2.92. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ProQR Therapeutics N.V (PRQR)

YearP/EChange
2026-2.92-33.81%
2025-4.41-39.30%
2024-7.27+77.79%
2023-4.09+13.85%
2022-3.59-49.84%
2021-7.16+83.47%
2020-3.90-39.99%
2019-6.50-47.79%
2018-12.45+633.61%
2017-1.70-39.62%
2016-2.81-68.01%
2015-8.79-75.15%
2014-35.36N/A

Comparison ProQR Therapeutics N.V (PRQR) P/E with competitors

ProQR Therapeutics N.V (PRQR) P/E is -2.92.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.10-103.50%
ENLVEnlivex Therapeutics Ltd0.15-105.15%
FGENFibroGen Inc0.24-108.22%
TRAWTraws Pharma Inc0.47-116.20%
FBIOFortress Biotech Inc0.71-124.18%
CHRSCoherus Biosciences Inc0.98-133.50%
ORMPOramed Pharmaceuticals Inc1.47-150.47%
AGENAgenus Inc2.05-170.17%
VIVSVivoSim Labs Inc2.54-186.86%
INVAInnoviva Inc3.19-209.22%
CRMDCorMedix Inc3.65-224.88%
ABEOAbeona Therapeutics Inc4.20-244.04%
VXRTVaxart Inc4.26-245.98%
CVACCureVac N.V.4.45-252.28%
SRPTSarepta Therapeutics Inc4.62-258.40%
GLPGGalapagos NV4.86-266.43%
RIGLRigel Pharmaceuticals4.92-268.51%
ZVRAZevra Therapeutics Inc4.97-270.38%
ABUSArbutus Biopharma Corp5.69-295.03%
CGENCompugen Ltd7.38-352.93%
AUPHAurinia Pharmaceuticals Inc9.25-416.90%
ACADAcadia Pharmaceuticals Inc9.59-428.43%
OMEROmeros Corporation9.88-438.55%
PLXProtalix BioTherapeutics Inc9.91-439.43%
SPROSpero Therapeutics Inc10.73-467.71%
ADMAAdma Biologics Inc11.33-488.12%
SVASinovac Biotech Ltd11.44-491.73%
TBPHTheravance Biopharma Inc11.78-503.40%
HRMYHarmony Biosciences Holdings Inc12.18-517.23%
TGTXTG Therapeutics Inc13.18-551.45%
INCYIncyte Corp13.38-558.39%
SABSSAB Biotherapeutics Inc14.06-581.54%
XOMAXOMA Corp14.95-611.94%
REGNRegeneron Pharmaceuticals Inc14.98-613.14%
PBYIPuma Biotechnology Inc15.05-615.55%
EXELExelixis Inc15.79-641.04%
NAGENiagen Bioscience Inc16.35-660.23%
CPRXCatalyst Pharmaceuticals Inc17.34-694.14%
MDXGMimedx Group Inc17.38-695.18%
ARGXArgen X SE23.07-890.31%
HALOHalozyme Therapeutics Inc23.20-894.73%
XOMAOXOMA Corp25.34-968.18%
VRTXVertex Pharmaceuticals Inc25.66-978.83%
XOMAPXOMA Corp25.67-979.32%
CTMXCytomX Therapeutics Inc25.70-980.27%
ASNDAscendis Pharma A/S26.35-1002.75%
RPRXRoyalty Pharma plc - Class A27.50-1041.84%
SLNOSoleno Therapeutics Inc29.02-1093.91%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1134.03%
BMRNBiomarin Pharmaceutical Inc37.51-1384.80%
APLSApellis Pharmaceuticals Inc39.02-1436.65%
KRYSKrystal Biotech Inc39.70-1459.82%
GMABGenmab40.20-1477.16%
ONCBeiGene Ltd67.03-2395.98%
TECHBio-Techne Corp68.59-2449.70%
VCELVericel Corp80.63-2861.92%
PHARPharming Group N.V.87.74-3105.51%
ALNYAlnylam Pharmaceuticals Inc124.93-4379.56%
TLXTelix Pharmaceuticals Ltd139.89-4891.90%
CORTCorcept Therapeutics Inc158.39-5525.57%